BioArctic.

No events began in the chosen period. Widen it, or reset.

• FDA Structural
  FDA oversees drug trials in the US and Israel for Clearmind Medicine Inc., which is listed on Nasdaq.
  Moves BioArctic

  15:43
• Biogen Structural
  Bank of America updated its price objective and rating, while Citigroup reissued a neutral rating on Biogen shares.
  Moves BioArctic

  Wed 12:15
• Eli Lilly and Company Operational
  Mastercard, Eli Lilly, and Visa are noted as holdings within the Vanguard Morningstar Growth ETF (VUG).
  Moves BioArctic

  15:04
• Novartis Operational
  Bristol-Myers Squibb paused clinical trials following clinical setbacks reported by Novartis.
  Moves BioArctic

  14:21
• London Shared context
  A minister addresses compliance issues in London.
  Moves BioArctic

  13:11
• Boston Shared context
  A Boston-based firm, involving James Watson, launched US Propane in Georgia.
  Moves BioArctic

  14:34

• Biogen Structural

  BioArctic provided foundational IP that led to a current joint venture with Biogen, evidenced by shared financial reporting.

  Some supportOct 30
  BioArctic → Biogen

  Biogen → BioArctic
• FDA Structural

  BioArctic's drug development and commercialization are formally dependent on regulatory designation and approval from the FDA.

  Some supportOct 30
  BioArctic → FDA

  FDA → BioArctic
• Eisai Operational

  BioArctic and Eisai maintain a strategic research alliance for the co-development and commercialization of Leqembi.

  Some supportOct 30
  BioArctic → Eisai

  Eisai → BioArctic
• Lars Lannfelt Structural

  BioArctic's antibody development and innovation are founded upon research findings by Lars Lannfelt.

  Some supportSep 22
  BioArctic → Lars Lannfelt

  Lars Lannfelt → BioArctic
• Novartis Operational

  Novartis and BioArctic entered into a partnership, which was later discontinued by Novartis.

  Some supportNov 2
  BioArctic → Novartis

  Novartis → BioArctic
• Eli Lilly and Company Operational

  The companies are engaged in research collaboration regarding potential treatments for neurodegenerative diseases.

  Well supportedAug 26
  BioArctic → Eli Lilly and Company

  Eli Lilly and Company → BioArctic
• London Shared context

  BioArctic presented a study at a conference held in London.

  Some supportAug 26
  BioArctic → London

  London → BioArctic
• Boston Shared context

  BioArctic is observed conducting activities within the context of Boston.

  Some supportOct 30
  BioArctic → Boston

  Boston → BioArctic